Whole-Exome Sequencing (WES)
Why in News?
Scientists recently used WES to identify a previously unknown rare genetic condition, demonstrating its power in solving "diagnostic odysseys".
About
- Whole-Exome Sequencing (WES) is a cutting-edge genetic technique used to sequence only the exons—the protein-coding regions of the human genome. While these regions make up less than 2% of our total DNA, they harbour approximately 85% of all known disease-causing mutations.
- Bangla Dibas & Health Initiatives: As part of state-level health expansions, WES is being integrated into specialized diagnostic centers for personalized medicine.
- Newborn Screening Breakthroughs: Large-scale studies (like the "Generation Study" in the UK and pilot projects in Russia) are using WES to screen newborns for hundreds of treatable conditions that traditional tests might miss.
- Rapid Market Growth: The global WES market is projected to grow from $2.08 billion in 2026 to over $5.9 billion by 2032, driven by its use in clinical oncology and precision medicine.
Key Information
- Targeted Approach: Unlike Whole-Genome Sequencing (WGS), which reads all 3 billion letters of DNA, WES focuses strictly on the exome (the complete set of exons).
- Cost-Effective & Faster: WES is significantly cheaper and yields more manageable data than WGS, making it a more practical choice for routine clinical use.
- Diagnostic Power: It has a success rate of about 31% for identifying the cause of mysterious symptoms, particularly in children with developmental delays or rare syndromes.
- Precision Medicine: WES is used in cancer treatment to identify specific mutations in a tumor, allowing doctors to select targeted therapies or immunotherapies.
WES vs. WGS
| Feature |
Whole-Exome (WES) |
Whole-Genome (WGS) |
| Genome Coverage |
~1% to 2% (Coding regions) |
100% (Coding + non-coding) |
| Mutation Detection |
85% of disease variants |
All variants, including structural |
| Cost |
Much lower (Economical) |
High (Expensive) |
| Data Size |
Small (Easier to analyze) |
Massive (High storage needs) |
Recent Limitations
- Misses Non-Coding DNA: It cannot detect mutations in the introns (non-coding regions) or regulatory areas, which account for about 15% of disease-causing variants.
- Structural Variations: WES struggles to identify large structural changes or "repeat expansions" in the DNA.
- Interpretation Challenges: It may return "Variants of Uncertain Significance" (VUS)—changes in the DNA where it is unclear if they actually cause disease.
Download Pdf
